Latest Non-alcoholic fatty liver disease Stories
FRENCHS FOREST, Australia and INGELHEIM, Germany, May 18, 2015 /PRNewswire/ -- -- Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis'
Analysis of over 200,000 patients has been selected for a Guided Poster Tour at the upcoming AACE Annual Meeting New York, NY (PRWEB) May 15, 2015 Medivo,
- Nonalcoholic Steatohepatitis is a progressive liver disease associated with increased risk for liver cirrhosis, hepatocellular cancer, metabolic and cardiovascular disease - MODI'IN,
RnRMarketResearch.com adds “Fatty Liver Disease – Pipeline Review, H1 2015” to its store.
LOS ANGELES, April 8, 2015 /PRNewswire/-- Endonovo Therapeutics, Inc.
New research report “Nonalcoholic Steatohepatitis: KOL Insight” created by FirstWord is now available at MarketPublishers.com. London, UK (PRWEB) April 02,
TEL AVIV, Israel, March 17, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
LONDON, March 9, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides
TEL AVIV, Israel, March 9, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
Initial Phase 1 Safety Study Successfully Completed, Building on Promising Body of Preclinical Data CUPERTINO, Calif., March 2, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX)
- A young chicken: also used as a pet name for children.